Basal/triple-negative breast cancers (TNBCs) show enrichment of CD44+/CD24- CSCs, whereas luminal breast cancers are enriched for ALDEFLUOR+ CSCs13, 14, 15, 16. This evidence concerns the gene CD44 and breast carcinoma.